Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
作者信息
Humbert Marc, Lau Edmund M T
机构信息
Service de Pneumologie et Soins Intensifs Respiratoires Hôpital Bicêtre (Assistance Publique Hôpitaux de Paris) Le Kremlin Bicêtre, France.
Faculté de Medicine Université Paris-Saclay Le Kremlin-Bicêtre, France.
出版信息
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.
Abstract
摘要
相似文献
1
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.
2
Pulmonary arterial hypertension registries: past, present and into the future.
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.
3
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
4
The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1312-1315. doi: 10.1164/rccm.201902-0266LE.
5
[Heritable pulmonary arterial hypertension].
Inn Med (Heidelb). 2024 Jun;65(6):560-565. doi: 10.1007/s00108-024-01718-y. Epub 2024 May 21.
6
Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.
Eur Respir Rev. 2020 Feb 5;29(155). doi: 10.1183/16000617.0089-2019. Print 2020 Mar 31.
7
Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
Chest. 2020 Dec;158(6):2546-2555. doi: 10.1016/j.chest.2020.06.053. Epub 2020 Jul 3.
8
Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?
Am J Respir Crit Care Med. 2019 Mar 15;199(6):799-802. doi: 10.1164/rccm.201806-1027LE.
9
Evaluation and management of pulmonary arterial hypertension.
Respir Med. 2020 Sep;171:106099. doi: 10.1016/j.rmed.2020.106099. Epub 2020 Aug 19.
10
Idiopathic pulmonary arterial hypertension with coexisting CHD.
Cardiol Young. 2018 May;28(5):743-746. doi: 10.1017/S1047951117002876. Epub 2018 Jan 10.
引用本文的文献
1
Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A Randomized Controlled Study.
Medicina (Kaunas). 2022 May 14;58(5):662. doi: 10.3390/medicina58050662.
本文引用的文献
1
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
Eur Respir J. 2021 Feb 25;57(2). doi: 10.1183/13993003.00414-2020. Print 2021 Feb.
2
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Am J Respir Crit Care Med. 2021 Mar 15;203(6):761-764. doi: 10.1164/rccm.202010-3967LE.
3
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
Eur Respir J. 2021 Feb 25;57(2). doi: 10.1183/13993003.00124-2020. Print 2021 Feb.
4
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.
5
The importance of patient perspectives in pulmonary hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01919-2018. Print 2019 Jan.
6
Risk stratification and medical therapy of pulmonary arterial hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01889-2018. Print 2019 Jan.
7
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
Chest. 2018 Oct;154(4):848-861. doi: 10.1016/j.chest.2018.04.027. Epub 2018 Apr 26.
8
Risk assessment in pulmonary arterial hypertension.
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.00279-2018. Print 2018 Mar.
9
Risk assessment in pulmonary arterial hypertension.
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.02606-2017. Print 2018 Mar.
10
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.
Zotero 插件